Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › dorzolamide

dorzolamide

2 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Carbonic anhydrase inhibitors and DEXi show superior CMT reduction in retinitis pigmentosa macular oedema
Ophthalmology Sys. Review
Carbonic anhydrase inhibitors and DEXi show superior CMT reduction in retinitis pigmentosa macular oedema New Analysis Compares Treatments for Retinitis Pigmentosa Macular Oedema
This network meta-analysis evaluates various treatments for retinitis pigmentosa (RP)-associated macular oedema. The study found that carbon…
Different medications show varying success in reducing swelling and improving vision for patients with retinitis pigmentosa-associated macul…
Jul 24, 2026
Brinzolamide/timolol provides greater morning IOP reduction and lower eye irritation than dorzolamide/timolol
Ophthalmology Meta-analysis
Brinzolamide/timolol provides greater morning IOP reduction and lower eye irritation than dorzolamide/timolol Brinzolamide and Timolol Show Better Morning Pressure Reduction for Glaucoma
This systematic review and meta-analysis of 1885 patients found that brinzolamide/timolol (BT) achieved a statistically greater reduction in…
A new analysis shows that the combination of brinzolamide and timolol may lower morning eye pressure more than dorzolamide and timolol.
Jul 5, 2026